The FDA says they are considering ending authorization for healthy children between 6 months and 5 years old. Melania Trump ...

The U.S. Food and Drug Administration may not renew its authorization for Pfizer's COVID-19 vaccine approved for children ...

The Food and Drug Administration is considering pulling its authorization of Pfizer’s COVID-19 vaccine for healthy children ...

The Trump administration’s COVID-revenge campaign has laid the groundwork for Kennedy’s larger agenda.

Research and Development Expenses-- $4,700,000 compared to $5,600,000 during the prior year comparable period. Kodiak PCR ...

The move would add another barrier for parents who want to vaccinate healthy children ahead of the respiratory virus season.

Invivyd Aligns with U.S. FDA on Rapid Pathway to Full Approval (BLA) of Vaccine Alternative Monoclonal Antibody VYD2311 to Protect American Adults and Adolescents from COVID-19 ...

For the first time, many people in the United States who want to protect themselves against the flu this respiratory virus ...

The White House has blamed the Biden administration for failing to advance domestic production or fill the reserve.

The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...

Diagnostics' progress on their PCR platform, with key trials in 2025 and commercialization plans by 2026, targeting U.S. and global markets.

With the latest COVID-19 surge, information on testing and vaccinations for those who are uninsured is becoming hard to find.